Psychiatry & Neurology Doctors in Lyons, NY Accepting Medicare
5 Psychiatry & Neurology doctors found. Showing 1 - 5
 Dr. Harlan Kosson, M.D. Psychiatry & Neurology - Forensic Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1519 Nye Rd, Lyons, NY 14489 Phone: 845-294-0568 |
Odysseus Adamides Jr., M.D. Psychiatry & Neurology - Forensic Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1519 Nye Rd, Lyons, NY 14489 Phone: 315-946-5722 |
Dr. Ronald S Yearwood, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1519 Nye Rd Ste 110, Lyons, NY 14489 Phone: 315-946-5722 Fax: 315-946-7068 |
Ronald S Biviano, Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1519 Nye Road, Lyons, NY 14489 Phone: 315-946-5722 Fax: 315-946-7079 |
 Dr. Haidee I Pidor, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1519 Nye Rd, Lyons, NY 14489 Phone: 315-946-5722 Fax: 315-946-7068 |
News Archive
Prior GID diagnosis impacts health outcomes of patients with Parkinson's
A new study investigating the incidence and impact of gastrointestinal disorders (GID) among patients with Parkinson's disease (PD) found that patients who received both a PD diagnosis and a prior GID diagnosis appeared to have worse health outcomes compared to patients who received a diagnosis for PD with no prior GID diagnosis.
COVID-19 transmission unlikely to slow down dramatically during summer months
It is well known that rates of transmission of some respiratory viruses, including influenza, tend to fall during the summer months.
AbSorber expands business portfolio by acquiring Olerup
AbSorber strengthen its position on the important US market by acquiring NorDiag's share of Olerup Inc. AbSorber buys the company together with SSP Primers and after the transition will AbSorber own 50 percent of Olerup Inc. and SSP Primers 50 percent.
Menafrivac more effective, less expensive than older meningitis vaccines, studies say
The meningococcal vaccine MenAfriVac, which is made by the Indian generic drug company Serum Institute, is "dramatically better" at producing a protective effect among African children in three countries than "older so-called meningococcal polysaccaride vaccines, including Mencevax from GlaxoSmithKline," according to a paper describing two studies published in the New England Journal of Medicine, Reuters reports.
› Verified 5 days ago